Endocrine responses after d-fenfluramine and ipsapirone challenge : Further support for cloninger's tridimensional model of personality
The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whet...
Saved in:
Published in | Neuropsychobiology Vol. 41; no. 1; pp. 38 - 47 |
---|---|
Main Authors | , , , , |
Format | Conference Proceeding Journal Article |
Language | English |
Published |
Basel
Karger
2000
S. Karger AG |
Subjects | |
Online Access | Get full text |
ISSN | 0302-282X 1423-0224 |
DOI | 10.1159/000026631 |
Cover
Abstract | The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system. |
---|---|
AbstractList | The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system. The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system.The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system. |
Author | ROHRMANN, S TOLL, C HENNIG, J NETTER, P SCHONLAU, P |
Author_xml | – sequence: 1 givenname: J surname: HENNIG fullname: HENNIG, J organization: Department of Psychology, University of Giessen, Germany – sequence: 2 givenname: C surname: TOLL fullname: TOLL, C organization: Department of Psychology, University of Giessen, Germany – sequence: 3 givenname: P surname: SCHONLAU fullname: SCHONLAU, P organization: Department of Psychology, University of Giessen, Germany – sequence: 4 givenname: S surname: ROHRMANN fullname: ROHRMANN, S organization: Department of Psychology, University of Giessen, Germany – sequence: 5 givenname: P surname: NETTER fullname: NETTER, P organization: Department of Psychology, University of Giessen, Germany |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1491064$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10629434$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkE1LHTEUhoNY9Hrron-ghFJ0NW0-5k4Sd0XUFoRuWnA3ZDInGskk05yZhb-gf9uIVwo9mxfO-5wP3hNymHICQj5w9oXznfnKaomuk_yAbHgrZMOEaA_JhkkmGqHF3TE5QXxkjLdGmSNyzFknTCvbDfl7lcbsSkhAC-CcEwJS6xcodGw8JB_XYqcX26aRhhntHEq9Tt2DjRHSPdALer2W5aFO4DrPuSzU50JdzClUu5wjXUoYwwQJQ0420imPEGn2dIaCL52wPL0n77yNCKd73ZLf11e_Lr83tz9vflx-u23uJVdLI1XHPWNaGy06NwgzenDOi51X0jg-DMopP2it_E503gweFNfMSiV348CVk1ty9rp3LvnPCrj0U0AHMdoEecVeMd0ZVjPckk__gY95LfVZ7IWUFdBVtuTjHlqHCcZ-LmGy5al_y7cCn_eARWejLza5gP-41lS0lc_JSoxl |
CODEN | NPBYAL |
ContentType | Conference Proceeding Journal Article |
Copyright | 2000 INIST-CNRS Copyright 2000 S. Karger AG, Basel Copyright S. Karger AG Jan 2000 |
Copyright_xml | – notice: 2000 INIST-CNRS – notice: Copyright 2000 S. Karger AG, Basel – notice: Copyright S. Karger AG Jan 2000 |
DBID | IQODW CGR CUY CVF ECM EIF NPM 3V. 7TK 7U7 7X7 7XB 88A 88E 88G 88I 8AF 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7X8 |
DOI | 10.1159/000026631 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Toxicology Abstracts ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Psychology Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1423-0224 |
EndPage | 47 |
ExternalDocumentID | 48628730 10629434 1491064 |
Genre | Clinical Trial Randomized Controlled Trial Journal Article |
GroupedDBID | --- .GJ 0R~ 0~5 0~B 123 29N 30W 325 36B 3O. 3V. 4.4 53G 5RE 7X7 88A 88E 88I 8AF 8AO 8FE 8FH 8FI 8FJ 8UI AAKET AAYIC ABIVO ABPAZ ABPTK ABUWG ABZSI ACGFS ACGOD ACHQM ACNCT ACPRK ACPSR ADAGL ADBBV ADGES AENEX AEYAO AFFNX AFKRA AFRAH AHMBA ALDHI ALMA_UNASSIGNED_HOLDINGS AZPMC AZQEC BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 DWQXO E0A EBS EJD EMB EMOBN F5P FB. FYUFA GNUQQ HCIFZ HZ~ IQODW IY7 KUZGX LK8 M0L M1P M2M M2P M7P N9A O1H O9- OVD PQQKQ PROAC PSQYO PSYQQ RIG RKO RXVBD S0X SV3 TEORI UJ6 UKHRP ZGI ZXP ABBTS ABJNI ABWCG ACQXL AFJJK AFSIO AHFRZ ALIPV CGR CUY CVF CYUIP ECM EIF HMCUK NPM 7TK 7U7 7XB 8FK C1K K9. PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS PUEGO Q9U 7X8 |
ID | FETCH-LOGICAL-g317t-3761f00889826cb29dfeccf25f739c1bb7c7fb887f526f9bfe7180a3735db17c3 |
IEDL.DBID | 7X7 |
ISSN | 0302-282X |
IngestDate | Thu Sep 04 23:26:52 EDT 2025 Sat Aug 23 14:40:28 EDT 2025 Wed Feb 19 01:20:57 EST 2025 Sun Oct 22 16:07:50 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Ipsapirone Adenohypophyseal hormone Prolactin Adrenal hormone Fenfluramine Personality Serotonine receptor Serotonin agonist Hydrocortisone Glucocorticoid |
Language | English |
License | CC BY 4.0 Copyright 2000 S. Karger AG, Basel |
LinkModel | DirectLink |
MeetingName | Traits as Dispositions for Psychopathology |
MergedId | FETCHMERGED-LOGICAL-g317t-3761f00889826cb29dfeccf25f739c1bb7c7fb887f526f9bfe7180a3735db17c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 ObjectType-Undefined-3 |
PMID | 10629434 |
PQID | 233423823 |
PQPubID | 32889 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_70869042 proquest_journals_233423823 pubmed_primary_10629434 pascalfrancis_primary_1491064 |
PublicationCentury | 2000 |
PublicationDate | 2000 2000-00-00 20000101 |
PublicationDateYYYYMMDD | 2000-01-01 |
PublicationDate_xml | – year: 2000 text: 2000 |
PublicationDecade | 2000 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel – name: Switzerland |
PublicationTitle | Neuropsychobiology |
PublicationTitleAlternate | Neuropsychobiology |
PublicationYear | 2000 |
Publisher | Karger S. Karger AG |
Publisher_xml | – name: Karger – name: S. Karger AG |
SSID | ssj0014979 |
Score | 1.6719756 |
Snippet | The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the... |
SourceID | proquest pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 38 |
SubjectTerms | Adult Behavioral psychophysiology Biological and medical sciences Cross-Over Studies Double-Blind Method Fenfluramine - administration & dosage Fenfluramine - pharmacology Fundamental and applied biological sciences. Psychology Hormones and behavior Humans Hydrocortisone - blood Male Models, Neurological Neurotransmitter Agents - physiology Personality - physiology Personality Inventory Prolactin - blood Prospective Studies Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Pyrimidines - administration & dosage Pyrimidines - pharmacology Reference Values Serotonin Agents - administration & dosage Serotonin Agents - pharmacology |
Title | Endocrine responses after d-fenfluramine and ipsapirone challenge : Further support for cloninger's tridimensional model of personality |
URI | https://www.ncbi.nlm.nih.gov/pubmed/10629434 https://www.proquest.com/docview/233423823 https://www.proquest.com/docview/70869042 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwEB21cKlUVRTasnx1DhVciJo4XxsuFUW7Qj0ghEDa28qO7QoJsmm8e9g_wO9mxs7uqof27MhKMvbMG3vmPYBvuiqroWTVAAIHUWbyLBrm0kbKWq0JYSSp9myfN8X1Q_Zrkk_62hzXl1WufKJ31HpW8xn5d5EyV91QpD_aPxGLRvHlaq-g8Ra2E0IqvKjLyTrfIuwfqPZS34EsJj2xEAVwz9lIoYml5d630tHvsEHH4t9A0wec8Q586JEiXgbTfoQ3ptmFvcuGsuTnJZ6ir930h-K7cHobGKiX53i_aahy5_6xNTf1cg9eRg19Knf8YReqY41DrxOOOrKGFUs6-czDstH42DrZch-cwXolunKB40XHqBHdomXwjgR78erJH-ua7szhvHvUrBkQ-D7Qa-3gzGK7wf2f4GE8ur-6jnophug3AYw5u6HExlwSRelIrUSlLdneityWaVUnSpV1aRU5LJuLwlbKGop5sUzLNNcqKev0M2w19Lb7gDG3suqMsajOciuULAyBCEtYoRpmIh7A8V8WmbaBdoOSFII2RTaAw5WFpv1-c9P16hjA1_UobRS-_ZCNmS3ctIxZfCsTA_gSzLqZOC4E0-Qd_HfmQ3gX2vD5-OUItubdwhwTIJmrE7_sTmD75-jm9u4VS4jkUQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VcgAJIWj5WErpHKBcGjVrO8kGCaGqdLWlpeKwlfYWkthGldpsmuwK7R_g3_AfmbE3u-IAt54dWYlnxn7jzLwH8FanSTrIWTWAwEGgTKSCQZTboLBWa0IYfakd2-dFPLpUXybRZAN-d70wXFbZ7Yluo9bTku_ID4VkrrqBkJ_q24BFo_jnaqeg4b3izCx-UsbWfjz9TOZ9J8TwZHw8CpaiAsEPOipnHFB9G3JxDwHrshCptvQVVkQ2kWnZL4qkTGxBoWcjEdu0sIZ27zCXiYx00U9KSfPeg_tKhoqp-pPJKr-jXMNT-0nX8SwmSyIjAgyOI5KOQpaye1TnLS2_9boZ_wa27oAbPoHHS2SKR96VnsKGqbZg-6iirPxmgfvoakXdJfwW7H_zjNeLAxyvG7jaA_fYigt7sQ2_TipaWu4wxMZX45oWnS456sAaVkhp8hseziuNV3Wb19x3Z7DsRF4-4HDeMErFdl5zsoAEs_H42l0jm-Z9i7PmSrNGgecXQaftg1OL9TrPeAaXd2Kl57BZ0du-BAy5dVYrxr5aRVYUeWwItFjCJulAibAHu39ZJKs9zQclRQSlYtWDnc5C2TK-22zljT3YW41SYPLflrwy03mbJSGLfSnRgxferOuJw1gwLd-r_868Bw9G46_n2fnpxdkOPPQUAHz18xo2Z83c7BIYmhVvnAsifL9rn_8Drr4gEA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIiGkCkHLx1JK5wDl0qhZOx8bJISqtquWoqqHVtpbiGMbVaLZNNkV2j_Af-LfMWMnu-IAt54dWUlmxn5jz7wH8E5naTYqWDWAwEEQmTgKRnFhA2Wt1oQwhlI7ts-L5PQ6-jKJJ2vwu--F4bLKfk10C7WelnxGfiAkc9WNhDywXVXE5fH4c30XsIAUX7T2ahreQ87N4idlb-2ns2My9XshxidXR6dBJzAQfKdtc8bBNbQhF_oQyC6VyLSlL7IitqnMyqFSaZlaRWFoY5HYTFlDK3lYyFTGWg3TUtK8D-BhKiPJ1WTpZJnrUd7haf6k634Wk47UiMCD44ukbZFl7TbqoiVTWK-h8W-Q6za78VN40qFUPPRu9QzWTLUJW4cVZei3C9xDVzfqDuQ3Ye_Ss18v9vFq1czV7rvHlrzYiy34dVLRb-ZuQ2x8Za5p0WmUow6sYbWUprjl4aLSeFO3Rc09eAbLXvDlI47nDSNWbOc1Jw5IkBuPfrgjZdN8aHHW3GjWK_BcI-h0fnBqsV7lHM_h-l6s9ALWK3rbV4Aht9HqiHGwjmIrVJEYAjCWcEo2ikQ4gJ2_LJLXnvKDEiSCVUk0gO3eQnkX622-9MwB7C5HKUj55qWozHTe5mnIwl-RGMBLb9bVxGEimKLv9X9n3oVH5O3517OL82147NkA-BToDazPmrnZIVw0U2-dByJ8u2-X_wPHLCRL |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Neuropsychobiology&rft.atitle=Endocrine+responses+after+d-fenfluramine+and+ipsapirone+challenge+%3A+Further+support+for+cloninger%27s+tridimensional+model+of+personality&rft.au=HENNIG%2C+J&rft.au=TOLL%2C+C&rft.au=SCHONLAU%2C+P&rft.au=ROHRMANN%2C+S&rft.date=2000-01-01&rft.pub=Karger&rft.issn=0302-282X&rft.eissn=1423-0224&rft.volume=41&rft.issue=1&rft.spage=38&rft.epage=47&rft_id=info:doi/10.1159%2F000026631&rft.externalDBID=n%2Fa&rft.externalDocID=1491064 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0302-282X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0302-282X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0302-282X&client=summon |